La Jolla, CA, United States of America

Nathan C Gianneschi

This inventor holds 21 USPTO granted patents and 39 published patent applications, primarily in Peptide Polymers. Top assignees: University of California, Northwestern University, The University of Akron. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nathan C Gianneschi. Retrieved from https://idiyas.com/inventor/nathan-c-gianneschi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21 

% Patents Active = 95.2

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • La Jolla, CA (US) (2021)
  • Evanston, IL (US) (2022)
  • San Diego, CA (US) (2010 - 2024)
  • Wilmette, IL (US) (2024)

Company Filing History:


Years Active: 2010-2026

Loading Chart...
Areas of Expertise:
Peptide Brush Polymers
Bioactive Peptides
Melanin Particles
Nucleic Acids
Therapeutic Use
Cyclic Peptide
Supraparticles
Nanofibers
Gene Therapy
Signal Amplification
Cytotoxins
Polymerization
21 patents (USPTO):Explore Patents

Title: Nathan C. Gianneschi: Innovator and Researcher Pioneering Advancements in Nanotechnology and Tissue Engineering

Introduction: Nathan C. Gianneschi is a prominent inventor based in La Jolla, California, known for his groundbreaking contributions to the field of nanotechnology and tissue engineering. With a remarkable portfolio of 11 patents, Gianneschi has made significant strides in developing innovative solutions aimed at addressing various medical challenges.

Latest Patents: Among his latest patents is the development of synthetic melanin nanoparticles designed to protect keratinocytes from UV damage and to treat melanin-defective diseases. These synthetic melanin nanoparticles, or MelNPs, represent a significant advancement in dermatological science. Another noteworthy patent is for catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering. This invention features cyclic peptide pro-gelator compositions that assemble into a macromolecular hydrogel upon interaction with endogenous enzymes upregulated at sites of tissue injury, such as during myocardial infarction, thereby offering a novel approach to cardiac repair.

Career Highlights: Nathan C. Gianneschi has had an illustrious career, having worked at the University of California and Vybyl Holdings, Inc. His work at these institutions has propelled his research forward, allowing him to explore innovative technologies that can transform medical treatments.

Collaborations: Throughout his career, Gianneschi has collaborated with distinguished colleagues, including Cassandra E. Callmann and Matthew P. Thompson. These partnerships have fostered an environment of creativity and shared knowledge, leading to many of his successful inventions.

Conclusion: Nathan C. Gianneschi is a testament to the vital role of inventors in bridging the gap between science and practical applications. His contributions continue to impact healthcare positively, showcasing the importance of innovation in addressing some of the most pressing medical concerns in society today. Through his inventive spirit and dedication to research, Gianneschi is paving the way for future advancements in nanotechnology and tissue engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…